Regen BioPharma Files Q1 2025 10-Q
Ticker: RGBPP · Form: 10-Q · Filed: May 16, 2025 · CIK: 1589150
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
Related Tickers: RGBP
TL;DR
Regen BioPharma (RGBP) filed their Q1 2025 10-Q. Check financials.
AI Summary
Regen BioPharma Inc. filed its 10-Q for the period ending December 31, 2024. The filing covers the first quarter of their fiscal year, which began on October 1, 2024. The company is based in La Mesa, California, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides investors with an update on Regen BioPharma's financial performance and operational status for the first quarter of their fiscal year 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Regen BioPharma faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (End of the reporting period for this 10-Q filing.)
- 2025-05-16 — Filing Date (Date the 10-Q was officially submitted to the SEC.)
- Q1 — Quarter (Indicates this filing covers the first quarter of the fiscal year.)
Key Players & Entities
- Regen BioPharma Inc. (company) — Filer of the 10-Q
- 2024-12-31 (date) — End of reporting period
- 2025-05-16 (date) — Filing date
- La Mesa, CA (location) — Company's business address
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the period ending December 31, 2024, covering the first quarter of the fiscal year.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 16, 2025.
What is Regen BioPharma Inc.'s primary business sector?
Regen BioPharma Inc. operates in the Pharmaceutical Preparations sector, identified by SIC code 2834.
Where is Regen BioPharma Inc. located?
The company's business and mailing address is 4700 Spring St #304, La Mesa, CA 91942.
What fiscal year end does Regen BioPharma Inc. follow?
Regen BioPharma Inc. follows a fiscal year end of September 30.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 16, 2025 regarding Regen BioPharma Inc (RGBPP).